Modern approaches to the therapy of invasive mycoses in cancer patients

Abstract

There is an increase in the prevalence of Candida fluco-R, there is a transition from strains of C. albicans to C. non-albicans. Diagnosis of invasive fungal infections is based on a clinical picture and risk factor assessment with subsequent retrospective confirmation of the diagnosis by a microbiological method. Echinocandines are the drugs of choice in the therapy of invasive/systemic mycoses in cancer patients.

Keywords

• invasive candidiasis
• systemic candidiasis
• fluconazole
• echinocandines
• oncological patient